written by reader Scheduled for June 23 rd the CD19 Vaccine for cancer.

By backoffice, June 15, 2017

A small company located in Texas will release it’s findings and results
from 110 clinical trials on a treatment centered on a patients immune
system where the T cell will recognize and phagotize the cancer cell.
The release of their findings should lead to licensing fees that should
cause the price of the stock to explode.

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.

guest

12345

This site uses Akismet to reduce spam. Learn how your comment data is processed.

190 Comments
Inline Feedbacks
View all comments
judith617
judith617
June 28, 2017 1:47 pm

This is just now:
BLCM Bellicum Pharmaceuticals Inc $0.20 (1.52%) $20.00 $49.05 (3.82%)

MBRX Moleculin Biotech Inc $0.98 (49.49%) $98.00 $100.05 (51.06%)

So far is good!

Add a Topic
4668
👍 1
Alex
Member